Customize your JAMA Network experience by selecting one or more topics from the list below.
Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
In the Original Investigation entitled “Association of Testosterone Therapy With Mortality, Myocardial Infarction, and Stroke in Men With Low Testosterone Levels” published in the November 16, 2013, issue of JAMA (2013;310:1829-1836. doi:10.1001/jama.2013.280386), incorrect data appeared. The second paragraph of the Results section should have read, “We excluded the following patients from this cohort: 2798 patients who had initiated testosterone prior to coronary angiography; 1301 patients who had missing coronary anatomy data or whose coronary anatomy was categorized as other; 128 patients who had testosterone prescribed after MI because treatment decisions after an event were likely to be different and because coronary anatomy data to assess coronary disease severity were not uniformly available; 112 patients who had started testosterone prior to having a testosterone level checked; 100 patients who were women; 17 patients with hematocrit levels higher than 50%; 12 patients with PSA levels of 4.0 ng/mL or higher; and 9996 patients who had total testosterone levels of 300 ng/dL or higher.” Figure 1 should have included “1301 Missing coronary anatomy,” “128 Had testosterone therapy prescribed after myocardial infarction or stroke,” and “100 Women” in the box listing excluded patients. This article has been corrected online.
Incorrect Number of Excluded Patients Reported in the Text and Figure. JAMA. 2014;311(9):967. doi:10.1001/jama.2014.444
Create a personal account or sign in to: